Abstract
A double-blind comparison of medazepam 10 mg (‘Nobrium’) tds with fluphenazine 0·5 mg/nortriptyline 10 mg (‘Motival’) tds was conducted in general practice patients suffering from anxiety with mild depression. Patients were assessed on self-rating and Physician's Rating symptom scales, and by twenty-eight days fluphenazine/nortriptyline was shown to be superior to medazepam in relief of symptoms taken individually and as a whole, the level of significance reaching 0·1% on patients' self-ratings. A similar trend in favour of fluphenazine/nortriptyline was seen at seven days but only reached 5% significance levels for certain symptom clusters on the patient's self-ratings. The implications of these results for therapy with psychotropic drug combinations, and the treatment of psychiatric illness in general practice are discussed.
Get full access to this article
View all access options for this article.